SASKATOON, Saskatchewan, Nov. 26, 2024 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to...
L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - PCRX Canada NewsWire VANCOUVER...
Canadian Investment Regulatory Organization Trade Resumption - PCRX Canada NewsWire VANCOUVER, BC, Sept. 25, 2024 VANCOUVER, BC, Sept. 25, 2024...
SASKATOON, Saskatchewan, Sept. 25, 2024 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - PCRX Canada NewsWire VANCOUVER, BC...
Canadian Investment Regulatory Organization Trading Halt - PCRX Canada NewsWire VANCOUVER, BC, Sept. 25, 2024 VANCOUVER, BC, Sept. 25, 2024 /CNW/...
SASKATOON, Saskatchewan, Sept. 03, 2024 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to...
REGINA, Saskatchewan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.